Dengue vaccine (Merck Sharp & Dohme)

N/A

Report date: 2025/06/16 09:22:35

Base Information

Drug NameDengue vaccine (Merck Sharp & Dohme)
Drug Alias NameLive, Attenuated, Quadrivalent Dengue Vaccine (V181)V-181
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Vaccine type > Multivalent vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore +[9] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme CorpInstituto ButantanMerck Sharp & Dohme LLC
Inactive CompaniesN/A
Active IndicationsDengue
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A